Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis.
Josef S SmolenAlexandre SeprianoKaterina ChatzidionysiouJackie L NamDésirée Mfm van der HeijdeMaxime DougadosRonald van VollenhovenJohannes W BijlsmaGerd R BurmesterMarieke Scholte-VoshaarLouise FalzonRobert B M LandewéPublished in: Annals of the rheumatic diseases (2017)
These findings confirm the known safety pattern of bDMARDs, including both tumour necrosis factor-α inhibitor (TNFi) and non-TNFi, for the treatment of RA.